Picton Mahoney Asset Management’s Editas Medicine EDIT Stock Holding History

Picton Mahoney Asset Management’s Portfolio EDIT Stock Details EDIT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-14,906	Closed	-$17K	–	1028
2025 Q1	$17K	Buy	14,906 +1,821	+14%	+$2.68K	﹤0.01%	598
2024 Q4	$17K	Buy	13,085 +8,755	+202%	+$22.3K	﹤0.01%	537
2024 Q3	$15K	Buy	4,330 +3,489	+415%	+$15.2K	﹤0.01%	501
2024 Q2	$3K	Buy	+841	New	+$4.74K	﹤0.01%	548

Other funds holding EDIT

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

Picton Mahoney Asset Management's EDIT Position: Q2 2025 in Review

Picton Mahoney Asset Management sold out of Editas Medicine (EDIT) in Q2 2025, closing a stake of 14,906 shares — an estimated $17K sold.

Picton Mahoney Asset Management first reported a position in EDIT in Q2 2024 and held it in 4 quarters. The position peaked at $17K in Q1 2025. 194 funds tracked by Wall St. Rank hold EDIT as of Q2 2025.

Picton Mahoney Asset Management reported no remaining Editas Medicine position as of Q2 2025 after selling out during the quarter.
Picton Mahoney Asset Management sold 14,906 Editas Medicine shares in Q2 2025, an estimated $17K.
Picton Mahoney Asset Management first reported a position in Editas Medicine in Q2 2024 and held it in 4 quarters.
Picton Mahoney Asset Management's Editas Medicine position peaked at $17K in Q1 2025.
194 funds tracked by Wall St. Rank held Editas Medicine as of Q2 2025.

Based on Picton Mahoney Asset Management's 13F filing for Q2 2025, filed 12 Aug 2025.